All generic drug manufacturers are falling on the news that U. S. prosecutors are starting an investigation on price collusion among generic drug manufacturers.
Of note is that MYL has the least amount of loss among the stocks in the group on the news. The other stocks in the group are TEVA, LCI, IPXL, ENDP, and TARO.
There is speculation that charges could come down by the year-end. Since the government has not released information on charges and evidence, it is difficult to say what the future holds. Having said that, historically the kind of dip that is being experienced today is usually a buying opportunity.
